(E)-2-(4-Fluorostyryl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 25g

Pyridin-4-yl-acetonitrile, 95.0%, 10g

(3,5-Dimethyl-[1,2,4]triazol-1-yl)-acetic acid, 95.0%, 1g

Methyl 3-methoxybenzoate, 98.0%, 1g

(S)-ethyl 2-(2-benzyl-3-(4-nitrophenylsulfonyloxy)propanamido)acetate, 98%, 100mg

4-Bromo-2-(2,6-dichlorophenyl)oxazolo[5,4-c]pyridine, 95.0%, 250mg

4-Bromo-3-methoxy-1H-indazole, 95.0%, 250mg

endo-BCN-O-PNB, 1g

1-(Pyridazin-3-yl)ethanone, 95.0%, 5g

monoclonal de souris anti-kératine K20, IT-Ks20.8, 1 ml

N-Benzyl-N,N'-dimethylethylenediamine>98.0%(GC)(T)5g

tert-Butyl (3,3,3-trifluoro-2-hydroxypropyl)carbamate, 95.0%, 10g

Ethyl Tetrahydrofuran-2-acetate>98.0%(GC)25mL